CONTEXT: The complexity of genetic testing in Kallmann syndrome (KS) is growing and costly. Thus, it is important to leverage the clinical evaluations of KS patients to prioritize genetic screening. OBJECTIVE: The objective of the study was to determine which reproductive and nonreproductive phenotypes of KS subjects have implications for specific gene mutations. SUBJECTS: Two hundred nineteen KS patients were studied: 151 with identified rare sequence variants (RSVs) in 8 genes known to cause KS (KAL1, NELF, CHD7, HS6ST1, FGF8/FGFR1, or PROK2/PROKR2) and 68 KS subjects who remain RSV negative for all 8 genes. MAIN OUTCOME MEASURES: Reproductive and nonreproductive phenotypes within each genetic group were measured. RESULTS: Male KS subjects with KAL1 RSVs displayed the most severe reproductive phenotype with testicular volumes (TVs) at presentation of 1.5 ± 0.1 mL vs 3.7 ± 0.3 mL, P < .05 vs all non-KAL1 probands. In both sexes, synkinesia was enriched but not unique to patients with KAL1 RSVs compared with KAL1-negative probands (43% vs 12%; P < .05). Similarly, dental agenesis and digital bone abnormalities were enriched in patients with RSVs in the FGF8/FGFR1 signaling pathway compared with all other gene groups combined (39% vs 4% and 23% vs 0%; P < .05, respectively). Hearing loss marked the probands with CHD7 RSVs (40% vs 13% in non-CHD7 probands; P < .05). Renal agenesis and cleft lip/palate did not emerge as statistically significant phenotypic predictors. CONCLUSIONS: Certain clinical features in men and women are highly associated with genetic causes of KS. Synkinesia (KAL1), dental agenesis (FGF8/FGFR1), digital bony abnormalities (FGF8/FGFR1), and hearing loss (CHD7) can be useful for prioritizing genetic screening.
CONTEXT: The complexity of genetic testing in Kallmann syndrome (KS) is growing and costly. Thus, it is important to leverage the clinical evaluations of KS patients to prioritize genetic screening. OBJECTIVE: The objective of the study was to determine which reproductive and nonreproductive phenotypes of KS subjects have implications for specific gene mutations. SUBJECTS: Two hundred nineteen KS patients were studied: 151 with identified rare sequence variants (RSVs) in 8 genes known to cause KS (KAL1, NELF, CHD7, HS6ST1, FGF8/FGFR1, or PROK2/PROKR2) and 68 KS subjects who remain RSV negative for all 8 genes. MAIN OUTCOME MEASURES: Reproductive and nonreproductive phenotypes within each genetic group were measured. RESULTS: Male KS subjects with KAL1RSVs displayed the most severe reproductive phenotype with testicular volumes (TVs) at presentation of 1.5 ± 0.1 mL vs 3.7 ± 0.3 mL, P < .05 vs all non-KAL1 probands. In both sexes, synkinesia was enriched but not unique to patients with KAL1RSVs compared with KAL1-negative probands (43% vs 12%; P < .05). Similarly, dental agenesis and digital bone abnormalities were enriched in patients with RSVs in the FGF8/FGFR1 signaling pathway compared with all other gene groups combined (39% vs 4% and 23% vs 0%; P < .05, respectively). Hearing loss marked the probands with CHD7RSVs (40% vs 13% in non-CHD7 probands; P < .05). Renal agenesis and cleft lip/palate did not emerge as statistically significant phenotypic predictors. CONCLUSIONS: Certain clinical features in men and women are highly associated with genetic causes of KS. Synkinesia (KAL1), dental agenesis (FGF8/FGFR1), digital bony abnormalities (FGF8/FGFR1), and hearing loss (CHD7) can be useful for prioritizing genetic screening.
Authors: Balasubramanian Bhagavath; Robert H Podolsky; Metin Ozata; Erol Bolu; David P Bick; Anita Kulharya; Richard J Sherins; Lawrence C Layman Journal: Fertil Steril Date: 2006-03 Impact factor: 7.329
Authors: L M Oliveira; S B Seminara; M Beranova; F J Hayes; S B Valkenburgh; E Schipani; E M Costa; A C Latronico; W F Crowley; M Vallejo Journal: J Clin Endocrinol Metab Date: 2001-04 Impact factor: 5.958
Authors: Nelly Pitteloud; Astrid Meysing; Richard Quinton; James S Acierno; Andrew A Dwyer; Lacey Plummer; Eric Fliers; Paul Boepple; Frances Hayes; Stephanie Seminara; Viriginia A Hughes; Jinghong Ma; Pierre Bouloux; Moosa Mohammadi; William F Crowley Journal: Mol Cell Endocrinol Date: 2006-06-09 Impact factor: 4.102
Authors: R Quinton; V M Duke; A Robertson; J M Kirk; G Matfin; P A de Zoysa; C Azcona; G S MacColl; H S Jacobs; G S Conway; M Besser; R G Stanhope; P M Bouloux Journal: Clin Endocrinol (Oxf) Date: 2001-08 Impact factor: 3.478
Authors: M I Stamou; P Varnavas; M Kentrou; F Adamidou; A Voutetakis; J Jing; L Plummer; V Koika; N A Georgopoulos Journal: Eur J Endocrinol Date: 2016-11-24 Impact factor: 6.664
Authors: R Manara; A Salvalaggio; A Favaro; V Palumbo; V Citton; A Elefante; A Brunetti; F Di Salle; G Bonanni; A A Sinisi Journal: AJNR Am J Neuroradiol Date: 2014-04-30 Impact factor: 3.825
Authors: Valerie F Sidhoum; Yee-Ming Chan; Margaret F Lippincott; Ravikumar Balasubramanian; Richard Quinton; Lacey Plummer; Andrew Dwyer; Nelly Pitteloud; Frances J Hayes; Janet E Hall; Kathryn A Martin; Paul A Boepple; Stephanie B Seminara Journal: J Clin Endocrinol Metab Date: 2013-01-01 Impact factor: 5.958